Effect of electrochemical topology on detection sensitivity in MEA assay for drug-induced cardiotoxicity screening

Team members Yiguang Zhu and Dr. Paul Locke were co-authors on a recent article about the use of electrochemical topology to better optimize multielectrode array (MEA) performance for drug testing.

Read the article here

Next
Next

How Should the 3 R’s Be Revised and Why?